Are digital health companies aiming too low?

David Shaywitz observes that most digital health companies, like most biopharma companies, are focused on incremental improvements, rather than revolutionary advances, and concludes by suggesting that we need both.

Read the story

@andrewspong


Get The Weekly Scoop Email